GlassScriptPhysician profile
Praveen Datar
NPI 1053734657
$9,272.50
in general payments reported to CMS, 2019-2025
19 companies · $256 in 2025
The $256 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $272 · 2021: $630 · 2022: $7,506 · 2023: $255 · 2024: $353 · 2025: $256.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $478 · Food and Beverage: $386.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $478.06 |
| Food and Beverage | $386.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $7,507.87 | 2022-2023 | Da Vinci Surgical System |
| Glaxosmithkline, LLC. | $464.58 | 2020-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Merit Medical Systems INC | $353.30 | 2024 | Aero Stent and Delivery System |
| Ethicon INC. | $163.88 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $155.57 | 2020-2022 | |
| Actelion Pharmaceuticals US, INC. | $147.20 | 2020-2022 | |
| Astrazeneca Pharmaceuticals LP | $144.02 | 2020-2025 | Airsupra |
| Jazz Pharmaceuticals INC. | $79.52 | 2020-2021 | |
| Janssen Pharmaceuticals, INC | $52.35 | 2021 | |
| Grifols USA, LLC | $42.49 | 2021 | |
| Veran Medical Technologies, INC. | $27.10 | 2020-2021 | |
| Galvanize Therapeutics, INC | $21.38 | 2025 | Aliya System |
| Philips North America LLC | $21.18 | 2025 | Vest Therapy Und |
| Verona Pharma, INC. | $18.44 | 2025 | Ohtuvayre |
| United Therapeutics Corporation | $17.47 | 2020 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $16.34 | 2025 | |
| Regeneron Healthcare Solutions, INC. | $14.77 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $13.47 | 2020 | |
| Preventice Services, LLC | $11.57 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Praveen Datar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.